Bleeding Complications After Transcutaneous Kidney Biopsy in Patients With Systemic Amyloidosis: Single-Center Experience in 101 Patients

American Journal of Kidney Diseases

Volumn 52, Issue 6, 2008, Pages 1079-1083

  Soares, Sandra M ^a   Fervenza, Fernando C ^a   Lager, Donna J ^a   Gertz, Morie A ^a   Cosio, Fernando G ^a   Leung, Nelson ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

Amyloidosis; bleeding; complication; hematoma; renal biopsy

Indexed keywords

ADULT; AGED; AMYLOIDOSIS; ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING; BLOOD TRANSFUSION; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; KIDNEY ANGIOGRAPHY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 54949089153     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.05.022     Document Type: Article

References (25)

1. Korbet S.M. Percutaneous renal biopsy. Semin Nephrol 22 (2002) 254-267
2. Kovalik E.C., Schwab S.J., Gunnells J.C., Bowie D., and Smith S.R. No change in complication rate using spring-loaded gun compared to traditional percutaneous renal allograft biopsy techniques. Clin Nephrol 45 (1996) 383-385
3. Fraser I.R., and Fairley K.F. Renal biopsy as an outpatient procedure. Am J Kidney Dis 25 (1995) 876-878
4. Parrish A.E. Complications of percutaneous renal biopsy: A review of 37 years' experience. Clin Nephrol 38 (1992) 135-141
5. Prakash J., Singh M., Tripathi K., and Rai U.S. Complications of percutaneous renal biopsy. J Indian Med Assoc 92 (1994) 395-396
6. Song J.H., and Cronan J.J. Percutaneous biopsy in diffuse renal disease: Comparison of 18- and 14-gauge automated biopsy devices. J Vasc Interv Radiol 9 (1998) 651-655
7. Preda A., Van Dijk L.C., Van Oostaijen J.A., and Pattynama P.M. Complication rate and diagnostic yield of 515 consecutive ultrasound-guided biopsies of renal allografts and native kidneys using a 14-gauge Biopty gun. Eur Radiol 13 (2003) 527-530
8. Whittier W.L., and Korbet S.M. Renal biopsy: Update. Curr Opin Nephrol Hypertens 13 (2004) 661-665
9. Hergesell O., Felten H., Andrassy K., Kuhn K., and Ritz E. Safety of ultrasound-guided percutaneous renal biopsy-Retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant 13 (1998) 975-977
10. Manno C., Strippoli G.F., Arnesano L., et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 66 (2004) 1570-1577
11. Eiro M., Katoh T., and Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol 9 (2005) 40-45
12. Palladini G., Perfetti V., and Merlini G. Therapy and management of systemic AL (primary) amyloidosis. Swiss Med Wkly 136 (2006) 715-720
13. Merlini G., and Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 349 (2003) 583-596
14. Bergesio F., Ciciani A.M., Santostefano M., et al. Renal involvement in systemic amyloidosis-An Italian retrospective study on epidemiological and clinical data at diagnosis. Nephrol Dial Transplant 22 (2007) 1608-1618
15. Kyle R.A., and Gertz M.A. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 32 (1995) 45-59
16. Pepys M.B. Pathogenesis, diagnosis and treatment of systemic amyloidosis. Philos Trans R Soc Lond B Biol Sci 356 (2001) 203-210 discussion, 210-211
17. Lachmann H.J., Booth D.R., Booth S.E., et al. : Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. [see comment]. N Engl J Med 346 346 (2002) 1786-1791
18. Yood R.A., Skinner M., Rubinow A., Talarico L., and Cohen A.S. Bleeding manifestations in 100 patients with amyloidosis. JAMA 249 (1983) 1322-1324
19. Mumford A.D., O'Donnell J., Gillmore J.D., Manning R.A., Hawkins P.N., and Laffan M. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol 110 (2000) 454-460
20. Sucker C., Hetzel G.R., Grabensee B., Stockschlaeder M., and Scharf R.E. Amyloidosis and bleeding: Pathophysiology, diagnosis, and therapy. Am J Kidney Dis 47 (2006) 947-955
21. Choufani E.B., Sanchorawala V., Ernst T., et al. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: Incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood 97 (2001) 1885-1887
22. Enjeti A.K., Walsh M., and Seldon M. Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis. Haemophilia 11 (2005) 535-538
23. Ralls P.W., Barakos J.A., Kaptein E.M., et al. Renal biopsy-related hemorrhage: Frequency and comparison of CT and sonography. J Comput Assist Tomogr 11 (1987) 1031-1034
24. Nicholson M.L., Wheatley T.J., Doughman T.M., et al. A prospective randomized trial of three different sizes of core-cutting needle for renal transplant biopsy. Kidney Int 58 (2000) 390-395
25. Gazelle G.S., Haaga J.R., and Rowland D.Y. Effect of needle gauge, level of anticoagulation, and target organ on bleeding associated with aspiration biopsy. Work in progress. Radiology 183 (1992) 509-513